COMPASS PATHWAYS PLC (CMPS) Payables and obligations
- Other obligations · latest quarter (USD): Value (m); Formula and calculation Total liabilities − borrowing debt − payables − total deferred revenue. Includes accruals, taxes, leases and other obligations; excludes the separately shown balances. Period ending 2026-06-30..
- Payables · latest quarter (USD): Value $12.24M; Formula and calculation Amounts owed to suppliers, reported accounts payable. Period ending 2026-06-30..
- Deferred revenue · latest quarter (USD): Value (m); Formula and calculation Current and noncurrent customer contract obligations; payments received before revenue is earned. Period ending 2026-06-30..
- Other obligations · due within 1 year (USD): Value (m); Formula and calculation Reported other current liabilities. Excludes separately reported debt, payables and current deferred revenue. The saved current-quarter facts do not separately disclose taxes, payroll, leases or accruals. Period ending 2026-06-30..
Payables and obligations
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Other obligations · latest quarter (USD) | (m) | Total liabilities − borrowing debt − payables − total deferred revenue. Includes accruals, taxes, leases and other obligations; excludes the separately shown balances. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Payables · latest quarter (USD) | $12.24M | Amounts owed to suppliers, reported accounts payable. Period ending 2026-06-30. Reported amount: $12.24M |
| Deferred revenue · latest quarter (USD) | (m) | Current and noncurrent customer contract obligations; payments received before revenue is earned. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Other obligations · due within 1 year (USD) | (m) | Reported other current liabilities. Excludes separately reported debt, payables and current deferred revenue. The saved current-quarter facts do not separately disclose taxes, payroll, leases or accruals. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Other obligations · due after 1 year (USD) | (m) | Reported other noncurrent liabilities minus the noncurrent deferred revenue they include (total customer contract obligations − current portion); a separately reported noncurrent deferred revenue line is not deducted. The saved current-quarter facts do not separately disclose taxes, leases or other accruals. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Total reported obligations | 420.03M USD | Liabilities |
| Borrowing debt | (m) | Long-term Debt, Current Maturities · Long-term Debt, Excluding Current Maturities |
| Amounts owed to suppliers | 12.24M USD | Accounts Payable, Current |
| Total deferred revenue | (m) | |
| Deferred revenue due within one year | (m) | |
| Deferred revenue due after one year | (m) | |
| Reported other obligations due within one year | (m) | Other Liabilities, Current |
| Reported other noncurrent obligations | (m) | |
| Deferred revenue included in other noncurrent obligations | (m) |
Other obligations breakdown
- Other obligations · due within 1 year (USD)
- (m)
- Other obligations · due after 1 year (USD)
- (m)
Bonds and commercial paper are already included in Total debt. Other obligations include taxes, accrued expenses and operating/finance leases. Category amounts below are the issuer’s own tagged balances at the same quarter end; untagged categories are not shown.
| Category | Quarter ending 2026-06-30 |
|---|---|
| Operating lease obligations | $3.90M |
These categories are parts of the combined obligations, not additional deductions.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Other obligations | Payables | Deferred revenue | Short-term obligations | Long-term obligations | Total reported obligations (USD) | Borrowing debt (USD) | Deferred revenue due within one year (USD) | Deferred revenue due after one year (USD) | Reported other noncurrent obligations (USD) | Deferred revenue included in other noncurrent obligations (USD) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | $12.24M | (m) | (m) | (m) | $420.03M | (m) | (m) | (m) | (m) | (m) |
| 2026-03-31 | (m) | $10.88M | (m) | (m) | (m) | $205.05M | (m) | (m) | (m) | (m) | (m) |
| 2025-12-31 | (m) | $15.22M | (m) | $559.00K | (m) | $263.20M | (m) | (m) | (m) | (m) | (m) |
| 2025-09-30 | (m) | $5.25M | (m) | (m) | (m) | $218.02M | (m) | (m) | (m) | (m) | (m) |
| 2025-06-30 | (m) | $10.93M | (m) | (m) | (m) | $130.98M | (m) | (m) | (m) | (m) | (m) |
| 2025-03-31 | (m) | $8.58M | (m) | (m) | (m) | $123.67M | (m) | (m) | (m) | (m) | (m) |
| 2024-12-31 | (m) | $12.28M | (m) | $1.32M | (m) | $58.97M | (m) | (m) | (m) | (m) | (m) |
| 2024-09-30 | (m) | $8.23M | (m) | (m) | (m) | $54.31M | (m) | (m) | (m) | (m) | (m) |
| 2024-06-30 | (m) | $8.20M | (m) | (m) | (m) | $52.26M | (m) | (m) | (m) | (m) | (m) |
| 2024-03-31 | (m) | $9.34M | (m) | $1.00M | (m) | $49.83M | (m) | (m) | (m) | (m) | (m) |
| 2023-12-31 | (m) | $5.89M | (m) | $1.02M | (m) | $50.24M | (m) | (m) | (m) | (m) | (m) |
| 2023-09-30 | (m) | $4.25M | (m) | $1.18M | (m) | $45.78M | (m) | (m) | (m) | (m) | (m) |
| 2023-06-30 | (m) | $1.98M | (m) | $628.00K | (m) | $43.44M | (m) | (m) | (m) | (m) | (m) |
| 2023-03-31 | (m) | $3.88M | (m) | $672.00K | (m) | $11.67M | (m) | (m) | (m) | (m) | (m) |
| 2022-12-31 | (m) | $4.76M | (m) | $656.00K | (m) | $16.01M | (m) | (m) | (m) | (m) | (m) |
| 2022-09-30 | (m) | $19.89M | (m) | $745.00K | (m) | $29.96M | (m) | (m) | (m) | (m) | (m) |
| 2022-06-30 | (m) | $3.35M | (m) | $720.00K | (m) | $14.05M | (m) | (m) | (m) | (m) | (m) |
| 2022-03-31 | (m) | $2.05M | (m) | $958.00K | (m) | $12.52M | (m) | (m) | (m) | (m) | (m) |
| 2021-12-31 | (m) | $2.56M | (m) | $268.00K | (m) | $16.49M | (m) | (m) | (m) | (m) | (m) |
| 2021-09-30 | (m) | $2.74M | (m) | $443.00K | (m) | $9.32M | (m) | (m) | (m) | (m) | (m) |
| 2021-06-30 | (m) | $3.89M | (m) | $440.00K | (m) | $7.80M | (m) | (m) | (m) | (m) | (m) |
| 2020-12-31 | (m) | $2.74M | (m) | $413.00K | (m) | $6.89M | (m) | (m) | (m) | (m) | (m) |
| 2019-12-31 | (m) | $1.26M | (m) | $37.00K | (m) | $23.87M | (m) | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ANI PHARMACEUTICALS INC (ANIP) | United States | $1.810B | 18.77 |
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |
| Xencor Inc (XNCR) | United States | $1.776B | -7.33 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Eton Pharmaceuticals, Inc. (ETON) | United States | $1.701B | 80.74 |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |